Michael Joseph Jacobs - 02 Jan 2024 Form 3/A Insider Report for ARROW FINANCIAL CORP (AROW)

Role
EVP, Chief Information Officer
Signature
Penko Ivanov, Attorney in Fact
Issuer symbol
AROW
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
3/A
Filing time
28 May 2024, 11:43:17 UTC
Date Of Original Report
29 Apr 2024
Next filing
30 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AROW Common Stock 4,282 02 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AROW Employee Stock Option (Right to Buy) 02 Jan 2024 Common Stock 1,231 $30.26 Direct F1
holding AROW Employee Stock Option (Right to Buy) 02 Jan 2024 Common Stock 1,195 $27.47 Direct F2
holding AROW Employee Stock Option (Right to Buy) 02 Jan 2024 Common Stock 1,160 $27.35 Direct F3
holding AROW Employee Stock Option (Right to Buy) 02 Jan 2024 Common Stock 1,688 $31.34 Direct F4
holding AROW Employee Stock Option (Right to Buy) 02 Jan 2024 Common Stock 1,230 $27.04 Direct F5
holding AROW Employee Stock Option (Right to Buy) 02 Jan 2024 Common Stock 2,122 $33.78 Direct F6
holding AROW Employee Stock Option (Right to Buy) 02 Jan 2024 Common Stock 3,090 $31.47 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vested 25% per year in equal installments on each of January 25, 2018; January 25, 2019; January 25, 2020; and January 25, 2021. These options are fully vested and exercisable.
F2 The options vested 25% per year in equal installments on each of January 31, 2019; January 31, 2020; January 31, 2021; and January 31, 2022. These options are fully vested and exercisable.
F3 The options vested 25% per year in equal installments on each of January 30, 2020; January 30, 2021; January 30, 2022; and January 30, 2023. These options are fully vested and exercisable.
F4 The options vested 25% per year in equal installments on each of January 29, 2021; January 29, 2022; January 29, 2023; and January 29, 2024. These options are fully vested and exercisable.
F5 The options vest 25% per year in equal installments, starting one year from the grant date. One quarter of the options vested and became exercisable on each of January 27, 2022; January 27, 2023; and January 27, 2024; one quarter will vest and become exercisable on January 27, 2025.
F6 The options vest 25% per year in equal installments, starting one year from the grant date. One quarter of the options vested and became exercisable on each of January 26, 2023 and January 26, 2024; one quarter will vest and become exercisable on each of January 26, 2025 and January 26, 2026.
F7 The options vest 25% per year in equal installments, starting one year from the grant date. One quarter of the options vested and became exercisable on February 1, 2024; one quarter will vest and become exercisable on each of February 1, 2025; February 1, 2026; and February 1, 2027.

Remarks:

This Form 3/A is filed to amend the Form 3 filed by the Reporting Person on April 29, 2024 (the "Original Form 3"). The Original Form 3 is hereby amended to update the vesting schedule of certain options issued to the Reporting Person.